These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [18F]Fluorodeoxyglucose PET in Thoracic Malignancies. Vilstrup MH; Torigian DA PET Clin; 2014 Oct; 9(4):391-420, v. PubMed ID: 26050944 [TBL] [Abstract][Full Text] [Related]
44. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer. Lee JW; Lee SM; Lee HS; Kim YH; Bae WK Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551 [TBL] [Abstract][Full Text] [Related]
45. (18)FDG-PET-scan in staging of primary malignant melanoma of the oesophagus: a case report. Vandewoude M; Cornelis A; Wyndaele D; Brussaard C; Kums R Acta Gastroenterol Belg; 2006; 69(1):12-4. PubMed ID: 16673556 [TBL] [Abstract][Full Text] [Related]
46. Value of positron emission tomography in diagnosing synchronous penile metastasis from urothelial bladder cancer. Rouanne M; Alhammadi A; Vilain D; Radulescu C; Lebret T World J Surg Oncol; 2015 Sep; 13():276. PubMed ID: 26376852 [TBL] [Abstract][Full Text] [Related]
47. Synchronous ovarian carcinoma detected on staging ¹⁸F-FDG PET/CT in a patient of esophageal carcinoma: a rare association. Mukherjee A; Sharma P; Karunanithi S; Jain S; Kumar R Rev Esp Med Nucl Imagen Mol; 2014; 33(5):308-9. PubMed ID: 25017383 [No Abstract] [Full Text] [Related]
48. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794 [TBL] [Abstract][Full Text] [Related]
50. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data. Barber TW; Duong CP; Leong T; Bressel M; Drummond EG; Hicks RJ J Nucl Med; 2012 Jun; 53(6):864-71. PubMed ID: 22582047 [TBL] [Abstract][Full Text] [Related]
51. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). Kut V; Spies W; Spies S; Gooding W; Argiris A Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894 [TBL] [Abstract][Full Text] [Related]
52. PET/CT in non-small cell lung cancer staging-promises and problems. Devaraj A; Cook GJ; Hansell DM Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691 [TBL] [Abstract][Full Text] [Related]
54. Early metabolic response on 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography after concurrent chemoradiotherapy for advanced stage III non-small cell lung cancer is correlated with local tumor control and survival. Jeong JU; Chung WK; Nam TK; Song JY; Yoon MS; Kim YC; Kim KS; Oh IJ; Ban HJ; Kwon SY; Bom HS; Ahn SJ Anticancer Res; 2014 May; 34(5):2517-23. PubMed ID: 24778069 [TBL] [Abstract][Full Text] [Related]
55. The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET). Alexander M; Brasić JR Clin Nucl Med; 2006 Sep; 31(9):566-7. PubMed ID: 16921288 [No Abstract] [Full Text] [Related]
57. Is there a role for positron emission tomography/computed tomography in the staging of small-cell lung cancer? Truong MT; Marom EM Clin Lung Cancer; 2008 Jan; 9(1):8. PubMed ID: 18282351 [No Abstract] [Full Text] [Related]